10月31日 - ** 制药商吉利德GILD.O股价盘前下跌1.6%至116.53美元
** 该公司第三季度的产品销售 (link)，下降2%，至73亿美元。
** 吉利德公司称其细胞疗法Yescarta和Tecartus的销售额在本季度有所下降
** 公司报告第三季度 利润为每小时 2.43 美元，分析师平均预期为每小时 2.13 美元 - LSEG 数据
** 第三季度总收入为 77.7 亿美元，同比增长 3%，分析师平均预期为 74.5 亿美元。
** 截至上次收盘，股价累计上涨 28.2
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.